Darrell S. Rigel

Aug 1, 2024 | statnews.com | Darrell S. Rigel

A decade after Sen. Jack Reed (D-R.I.) authored the Sunscreen Innovation Act, which became law in 2014, Americans are still waiting for newer, more effective sunscreen products due to the Food and Drug Administration’s chronic inaction. Ten years ago, Republicans and Democrats came together to pass this legislation with the promise of overcoming regulatory obstacles and ushering in a new era of sun protection.

Nov 21, 2023 | dermatologytimes.com | Darrell S. Rigel

November 21, 2023Darrel Rigel, MD, MS, sheds light on the rationale behind broad-spectrum sunscreens, emphasizing the imperative protection against UV radiation and the significance of both organic and inorganic sunscreen compounds. Panelists:Hilary Baldwin, MDAcne Treatment & Research CenterBrooklyn, New YorkCheri N. Frey, MDHoward UniversityWashington, DCKavita Mariwalla, MD, FAADMariwalla DermatologyWest Islip, New YorkAdelaide A.

Nov 13, 2023 | jofskin.org | Danny Zakria |Nicholas D. Brownstone |Darrell S. Rigel

Main Article Content Keywords melanoma, MIA, nomogram, sentinel lymph node biopsy, SLNB, survival, node positivity References 1. Zakria, D., Brownstone, N. & Rigel, D.

May 20, 2023 | jofskin.org | Todd E. Schlesinger |Leon Kircik |James Del Rosso |Darrell S. Rigel

Main Article Content Keywords actinic keratosis, topical treatment, tirbanibulin, patient-reported outcomes, clinician-reported outcomes Abstract Background: Patients' experiences regarding topical actinic keratosis (AK) treatments may optimize clinical outcomes. PROAK study aimed to evaluate patient- and clinician-reported outcomes among adult patients with AK on face or scalp who were prescribed tirbanibulin in real-world clinical practice in the United States. Methods: Key primary endpoint...

May 20, 2023 | jofskin.org | Darrell S. Rigel |Mark Lebwohl |Todd E. Schlesinger |April Armstrong

Main Article Content Keywords Actinic Keratosis, AK, PROAK, PROs, Patient Reported Outcomes, RWE, Real World Evidence, Skindex-16, Emotions, Functioning, Symptoms, QOL, Quality of Life, Tirbanibulin Abstract Objectives: Actinic Keratosis (AK) has been shown to negatively affect emotional functioning and skin-related quality of life of patients. Impact of tirbanibulin treatment in alleviating AK disease burden in patients with AKs is not adequately understood. Objective of the analysis is to...